Incyte Earnings
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 27, 2026
Fiscal period
Sep/2026
EPS estimate
$-3.87
Incyte earnings summary
Incyte is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $-3.87. In its most recent report on Apr 28, 2026 (Q1 2026), INCY posted EPS of $1.47. Revenue for the quarter was $1.27 billion.
Quarterly EPS is up 83.7% from the same quarter a year earlier. Across the last 16 reports, INCY shares moved an average of 3.8% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
INCY earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Apr 28, 2026 | — | $1.47 | — | +1.7% |
| Feb 10, 2026 | — | $1.46 | — | +0.2% |
| Oct 28, 2025 | — | $2.11 | — | +13.4% |
| Jul 29, 2025 | — | $2.04 | — | +3.7% |
| Apr 29, 2025 | — | $0.80 | — | -5.7% |
| Feb 10, 2025 | — | $0.90 | — | +2.4% |
| Oct 29, 2024 | — | $0.54 | — | +9.5% |
| Jul 30, 2024 | — | $-2.04 | — | -5.3% |
| Apr 30, 2024 | — | $0.75 | — | -1.3% |
| Feb 13, 2024 | — | $0.89 | — | +4.5% |
| Oct 31, 2023 | — | $0.76 | — | -4.4% |
| Aug 1, 2023 | — | $0.90 | — | +3.6% |
| May 2, 2023 | — | $0.10 | — | -1.9% |
| Feb 7, 2023 | — | $0.13 | — | -0.3% |
| Nov 1, 2022 | — | $0.50 | — | +0.3% |
| Aug 2, 2022 | — | $0.72 | — | +2.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.